1 / 5

Drug Discovery Software Market Analysis and Demand with Forecast to 2026

The market for drug discovery software (such as ligand-based design, structure-based design, LIMS, ELN) is driven by rising R&D spend and pipeline, expanding scope and scale, increasing stringency of testing and regulations, growing number and size of biotechs, need for increasing cost efficiencies and reducing time to market, and the shift to web/cloud-based software.

Tejashrik
Télécharger la présentation

Drug Discovery Software Market Analysis and Demand with Forecast to 2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Drug Discovery Software Market Size | Status | Top Players | Trends | Forecast to 2026

  2. The market for drug discovery software (such as ligand-based design, structure-based design, LIMS, ELN) is driven by rising R&D spend and pipeline, expanding scope and scale, increasing stringency of testing and regulations, growing number and size of biotechs, need for increasing cost efficiencies and reducing time to market, and the shift to web/cloud-based software. The global Drug Discovery Software market is valued at ~$2 billion in 2020 and is expected to grow at a CAGR of ~14% to cross $3.5 billion by 2025. This growth is being fueled by rising R&D spending across the globe, need for cost-efficiency & faster time-to-market, stringent regulatory compliance/reporting, growing use of AI & ML in drug discovery, and rising demand for novel software solutions specifically made for biologics/cell & gene therapy. Drug Discovery Software Market – Niche but Fast-Growing Market The drug discovery software market is niche and expanding quickly, driven by the growing pressure on the pharma and biotech companies to cut costs in the research and preclinical stage of drug development, decrease timelines and improve transparency through deep learning software tools.

  3. “Large players present in this segment are trying to consolidate the market by becoming a one stop shop. Moreover, companies are also considering to combine their solutions with bioinformatics and LIMS tools to have a competitive edge.” - Executive, Leading Drug Discovery Software Provider, US • Growing Focus on Developing AI/ML platforms for Drug Discovery • The advantages of using big data and AI/ML for drug discovery are being recognized by the life sciences industry more and more. Several AI/ML developments could be seen recently that are anticipated to disrupt the current drug discovery landscape. • For instance, • In Mar 2021, insitro, a ML-driven drug discovery and development company raised $400 million. In 2020, Optibrium launched Cerella, an AI software platform for drug discovery. • Explore Premium Report on Drug Discovery Software Market @ https://meditechinsights.com/drug-discovery-software-market/

  4. Rising Demand for Software Solutions Specifically Designed for Biologics Biologics are anticipated to expand rapidly during the drug discovery process. 50% of drugs currently in the preclinical phase are biologics. To leverage growth opportunities, companies are entering/expanding into biologics software space. Transition to Web/Cloud-based Software The drug discovery software industry is gradually shifting to cloud-based solutions as it can address most of the issues with on-premise installations and offer quick deployment, minimum upfront costs, high flexibility and scalability making it affordable for even small and medium size pharma/biotechs, academic research/universities and CROs. Competitive Landscape Analysis of Drug Discovery Software Market The global drug discovery software market is highly competitive and fragmented. Some of the key players include Dassault Systèmes, LabVantage, PerkinElmer, Schrodinger, Abbott, Healx, Optibrium, Instem, Chemical Computing Group, dotmatics, idbs, Titian, Biovia, Celsius, Genome Biologics, Atomwise, Standigm, insitro, and CytoReason.

  5. For More Detailed Insights, Contact Us @ https://meditechinsights.com/contact-us/ About Medi-Tech Insights Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services. Contact: RutaHalde Associate, Medi-Tech Insights +32 498 86 80 79 info@meditechinsights.com

More Related